drugset / Trial / NCT01260506
Single-Arm Open-Label Multicenter Study of VB-111 in Patients With Recurrent Glioblastoma Multiforme
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the safety, tolerability and efficacy of VB-111 in patients with Relapsed Glioblastoma Multiforme.
Timeline
- Start
- 2010-12
- Primary completion
- 2015-07-23
- Completion
- 2018-12-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | VB-111 | Other / unclassified | — | — |
| Background | Bevacizumab | Monoclonal antibody | — | — |